{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:11:31Z","timestamp":1789654291555,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,22]]},"DOI":"10.7759\/cureus.69901","type":"journal-article","created":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T11:32:11Z","timestamp":1727004731000},"source":"Crossref","is-referenced-by-count":1,"title":["Cryptogenic Organizing Pneumonia Is Associated With Increased Mortality Risk in Hospitalizations for Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis"],"prefix":"10.7759","author":[{"given":"Fidelis E","family":"Uwumiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arji","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Offiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnaedozie","family":"Umeani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaobi","family":"Ozigbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courage","family":"Idahor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Udegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobechukwu","family":"Chiegboka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihunanya","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magaret","family":"Utibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvis","family":"Enyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C","family":"Ayogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze B","family":"Eze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320967439","article-title":"Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: a review of three cases","volume":"30","author":"Baisya R","year":"2021","unstructured":"Baisya R, Devarasetti PK, Uppin SG, Narayanan R, Rajasekhar L, Sreejitha KS. Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: a review of three cases. Lupus. 2021, 30:336-41. 10.1177\/0961203320967439","journal-title":"Lupus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5152\/TurkThoracJ.2018.18008","article-title":"Cryptogenic and secondary organizing pneumonia: clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases","volume":"19","author":"Baha A","year":"2018","unstructured":"Baha A, Y\u0131ld\u0131r\u0131m F, K\u00f6kt\u00fcrk N, Galata Z, Aky\u00fcrek N, Demirci NY, T\u00fcrkta\u015f H. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases. Turk Thorac J. 2018, 19:201-8. 10.5152\/TurkThoracJ.2018.18008","journal-title":"Turk Thorac J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.12.659","article-title":"Algorithmic approach to the diagnosis of organizing pneumonia: a correlation of clinical, radiologic, and pathologic features","volume":"162","author":"Cherian SV","year":"2022","unstructured":"Cherian SV, Patel D, Machnicki S, et al.. Algorithmic approach to the diagnosis of organizing pneumonia: a correlation of clinical, radiologic, and pathologic features. Chest. 2022, 162:156-78. 10.1016\/j.chest.2021.12.659","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7389","article-title":"Organizing pneumonia as an initial presentation in a male lupus: a rare case report","volume":"11","author":"Acharya S","year":"2023","unstructured":"Acharya S, Aryal R, Yadav RK, Shrestha S, Karki R, Jha S. Organizing pneumonia as an initial presentation in a male lupus: a rare case report. Clin Case Rep. 2023, 11:e7389. 10.1002\/ccr3.7389","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1146782","article-title":"Update on cryptogenic organizing pneumonia","volume":"10","author":"Radzikowska E","year":"2023","unstructured":"Radzikowska E, Fijolek J. Update on cryptogenic organizing pneumonia. Front Med (Lausanne). 2023, 10:1146782. 10.3389\/fmed.2023.1146782","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226714","article-title":"Systemic lupus erythematosus and lung involvement: a comprehensive review","volume":"11","author":"Shin JI","year":"2022","unstructured":"Shin JI, Lee KH, Park S, et al.. Systemic lupus erythematosus and lung involvement: a comprehensive review. J Clin Med. 2022, 11:10.3390\/jcm11226714","journal-title":"J Clin Med"},{"key":"ref7","unstructured":"Introduction to the HCUP National Inpatient Sample (NIS). (2020). Accessed. March 1, 2024: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/NIS_Introduction_2016.jsp."},{"key":"ref8","unstructured":"NIS database documentation. (2024). Accessed. March 1, 2024: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp.."},{"key":"ref9","unstructured":"Introduction to the HCUP National Inpatient Sample. (2020). Accessed. March 1, 2024: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/NIS_Introduction_2017.jsp."},{"key":"ref10","unstructured":"HCUP methods series. (2020). Accessed. March 1, 2024: http:\/\/www.hcup-us.ahrq.gov\/reports\/methods\/methods.jsp.."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2022.02.113","article-title":"The National Inpatient Sample: a primer for neurosurgical big data research and systematic review","volume":"162","author":"Tang OY","year":"2022","unstructured":"Tang OY, Pugacheva A, Bajaj AI, Rivera Perla KM, Weil RJ, Toms SA. The National Inpatient Sample: a primer for neurosurgical big data research and systematic review. World Neurosurg. 2022, 162:e198-217. 10.1016\/j.wneu.2022.02.113","journal-title":"World Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.003846","article-title":"With great power comes great responsibility: big data research from the National Inpatient Sample","volume":"10","author":"Khera R","year":"2017","unstructured":"Khera R, Krumholz HM. With great power comes great responsibility: big data research from the National Inpatient Sample. Circ Cardiovasc Qual Outcomes. 2017, 10:10.1161\/CIRCOUTCOMES.117.003846","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the National Inpatient Sample","volume":"318","author":"Khera R","year":"2017","unstructured":"Khera R, Angraal S, Couch T, et al.. Adherence to methodological standards in research using the National Inpatient Sample. JAMA. 2017, 318:2011-8. 10.1001\/jama.2017.17653","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-022-01805-3","article-title":"All patient refined-diagnosis related groups' (APR-DRGs) severity of illness and risk of mortality as predictors of in-hospital mortality","volume":"46","author":"Santos JV","year":"2022","unstructured":"Santos JV, Viana J, Pinto C, Souza J, Lopes F, Freitas A, Lopes S. All patient refined-diagnosis related groups' (APR-DRGs) severity of illness and risk of mortality as predictors of in-hospital mortality. J Med Syst. 2022, 46:37. 10.1007\/s10916-022-01805-3","journal-title":"J Med Syst"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211040696","article-title":"Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren's syndrome: a literature review","volume":"13","author":"Depascale R","year":"2021","unstructured":"Depascale R, Del Frate G, Gasparotto M, et al.. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren's syndrome: a literature review. Ther Adv Musculoskelet Dis. 2021, 13:1759720X211040696. 10.1177\/1759720X211040696","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2009.01.002","article-title":"Respiratory manifestations of systemic lupus erythematosus: old and new concepts","volume":"23","author":"Pego-Reigosa JM","year":"2009","unstructured":"Pego-Reigosa JM, Medeiros DA, Isenberg DA. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol. 2009, 23:469-80. 10.1016\/j.berh.2009.01.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan L","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020, 16:19-30. 10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus","volume":"6","author":"Gottschalk TA","year":"2015","unstructured":"Gottschalk TA, Tsantikos E, Hibbs ML. Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol. 2015, 6:550. 10.3389\/fimmu.2015.00550","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117699","article-title":"Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sj\u00f6gren's syndrome: evidence- and practice-based guidance","volume":"14","author":"Marinho A","year":"2023","unstructured":"Marinho A, Delgado Alves J, Fortuna J, et al.. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sj\u00f6gren's syndrome: evidence- and practice-based guidance. Front Immunol. 2023, 14:1117699. 10.3389\/fimmu.2023.1117699","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41254","article-title":"Gender disparities in hospitalization outcomes and healthcare utilization among patients with systemic lupus erythematosus in the United States","volume":"15","author":"Uwumiro F","year":"2023","unstructured":"Uwumiro F, Okpujie VO, Osemwota O, et al.. Gender disparities in hospitalization outcomes and healthcare utilization among patients with systemic lupus erythematosus in the United States. Cureus. 2023, 15:e41254. 10.7759\/cureus.41254","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s1550-8579(04)80006-8","article-title":"Gender differences in systemic lupus erythematosus","volume":"1","author":"Yacoub Wasef SZ","year":"2004","unstructured":"Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend Med. 2004, 1:12-17. 10.1016\/s1550-8579(04)80006-8","journal-title":"Gend Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2017.01.005","article-title":"Systemic lupus erythematosus and lymphopenia: clinical and pathophysiological features (Article in French)","volume":"38","author":"Martin M","year":"2017","unstructured":"Martin M, Guffroy A, Argemi X, Martin T. Systemic lupus erythematosus and lymphopenia: clinical and pathophysiological features (Article in French). Rev Med Interne. 2017, 38:603-13. 10.1016\/j.revmed.2017.01.005","journal-title":"Rev Med Interne"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci155","article-title":"Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus","volume":"99","author":"Ng WL","year":"2006","unstructured":"Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM. 2006, 99:37-47. 10.1093\/qjmed\/hci155","journal-title":"QJM"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8431741","article-title":"Bronchiolitis obliterans organizing pneumonia as an initial presentation of systemic lupus erythematosus: a rare case report and literature review","volume":"2016","author":"Wang HP","year":"2016","unstructured":"Wang HP, Chen CM, Chen YY, Chen W. Bronchiolitis obliterans organizing pneumonia as an initial presentation of systemic lupus erythematosus: a rare case report and literature review. Case Rep Med. 2016, 2016:8431741. 10.1155\/2016\/8431741","journal-title":"Case Rep Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030276","article-title":"Respiratory manifestations in systemic lupus erythematosus","volume":"14","author":"Di Bartolomeo S","year":"2021","unstructured":"Di Bartolomeo S, Alunno A, Carubbi F. Respiratory manifestations in systemic lupus erythematosus. Pharmaceuticals (Basel). 2021, 14:10.3390\/ph14030276","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.610257","article-title":"Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus","volume":"7","author":"Amarnani R","year":"2020","unstructured":"Amarnani R, Yeoh SA, Denneny EK, Wincup C. Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus. Front Med (Lausanne). 2020, 7:610257. 10.3389\/fmed.2020.610257","journal-title":"Front Med (Lausanne)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary complications of systemic lupus erythematosus","volume":"40","author":"Hannah JR","year":"2019","unstructured":"Hannah JR, D'Cruz DP. Pulmonary complications of systemic lupus erythematosus. Semin Respir Crit Care Med. 2019, 40:227-34. 10.1055\/s-0039-1685537","journal-title":"Semin Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320903798","article-title":"Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies","volume":"29","author":"Al-Adhoubi NK","year":"2020","unstructured":"Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus. 2020, 29:355-63. 10.1177\/0961203320903798","journal-title":"Lupus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02435-9","article-title":"Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"23","author":"Jiang M","year":"2021","unstructured":"Jiang M, Chen R, Zhao L, Zhang X. Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis. Arthritis Res Ther. 2021, 23:57. 10.1186\/s13075-021-02435-9","journal-title":"Arthritis Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.07.001","article-title":"Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure","volume":"54","author":"Lai CC","year":"2021","unstructured":"Lai CC, Sun YS, Lin FC, Yang CY, Tsai CY. Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure. J Microbiol Immunol Infect. 2021, 54:1048-55. 10.1016\/j.jmii.2020.07.001","journal-title":"J Microbiol Immunol Infect"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43782-7","article-title":"Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study","volume":"9","author":"Enomoto N","year":"2019","unstructured":"Enomoto N, Egashira R, Tabata K, et al.. Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study. Sci Rep. 2019, 9:7355. 10.1038\/s41598-019-43782-7","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4237","article-title":"Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid","volume":"50","author":"Lee J","year":"2011","unstructured":"Lee J, Cha SI, Park TI, Park JY, Jung TH, Kim CH. Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid. Intern Med. 2011, 50:475-9. 10.2169\/internalmedicine.50.4237","journal-title":"Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.07.2967","article-title":"Mortality in patients with cryptogenic organizing pneumonia with and without connective tissue disease: a national retrospective cohort","volume":"164","author":"Guevara N","year":"2023","unstructured":"Guevara N, Francis-Morel G,  Perez E, et al.. Mortality in patients with cryptogenic organizing pneumonia with and without connective tissue disease: a national retrospective cohort. CHEST. 2023, 164:A4576. 10.1016\/j.chest.2023.07.2967","journal-title":"CHEST"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.556","article-title":"Steroid resistance in organizing pneumonia caused by pulmonary cryptococcosis","volume":"8","author":"Nomura M","year":"2020","unstructured":"Nomura M, Ohta H, Hiruta M, Kudo F, Ohyanagi F, Yamaguchi Y. Steroid resistance in organizing pneumonia caused by pulmonary cryptococcosis. Respirol Case Rep. 2020, 8:e00556. 10.1002\/rcr2.556","journal-title":"Respirol Case Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113639","article-title":"Steroids in lupus: enemies or allies","volume":"12","author":"Enr\u00edquez-Merayo E","year":"2023","unstructured":"Enr\u00edquez-Merayo E, Cuadrado MJ. Steroids in lupus: enemies or allies. J Clin Med. 2023, 12:10.3390\/jcm12113639","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia M","year":"2021","unstructured":"Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral infections and systemic lupus erythematosus: new players in an old story. Viruses. 2021, 13:10.3390\/v13020277","journal-title":"Viruses"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150916043","article-title":"Environmental factors, toxicants and systemic lupus erythematosus","volume":"15","author":"Mak A","year":"2014","unstructured":"Mak A, Tay SH. Environmental factors, toxicants and systemic lupus erythematosus. Int J Mol Sci. 2014, 15:16043-56. 10.3390\/ijms150916043","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S384256","article-title":"Gastrointestinal manifestations in patients with systemic lupus erythematosus","volume":"14","author":"Alharbi S","year":"2022","unstructured":"Alharbi S. Gastrointestinal manifestations in patients with systemic lupus erythematosus. Open Access Rheumatol. 2022, 14:243-53. 10.2147\/OARRR.S384256","journal-title":"Open Access Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23621","article-title":"Systemic lupus erythematosus vs. Mixed connective tissue disease disguised as scabies","volume":"14","author":"Liang R","year":"2022","unstructured":"Liang R, Landry I, Saliaj M. Systemic lupus erythematosus vs. Mixed connective tissue disease disguised as scabies. Cureus. 2022, 14:e23621. 10.7759\/cureus.23621","journal-title":"Cureus"},{"key":"ref40","article-title":"Cryptogenic organizing pneumonia","author":"Chandra D","year":"2024","unstructured":"Chandra D, Maini R, Hershberger DM. Cryptogenic organizing pneumonia. StatPearls Publishing, Treasure Island (FL); 2024."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290628-cryptogenic-organizing-pneumonia-is-associated-with-increased-mortality-risk-in-hospitalizations-for-systemic-lupus-erythematosus-sle-a-national-inpatient-sample-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T11:32:14Z","timestamp":1727004734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290628-cryptogenic-organizing-pneumonia-is-associated-with-increased-mortality-risk-in-hospitalizations-for-systemic-lupus-erythematosus-sle-a-national-inpatient-sample-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,22]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.69901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,22]]}}}